125 related articles for article (PubMed ID: 33901694)
41. Outcomes of Patients with Hepatocellular Carcinoma Treated with Conventional Transarterial Chemoembolization Using Guidance Software.
Miyayama S; Yamashiro M; Sugimori N; Ikeda R; Okimura K; Sakuragawa N
J Vasc Interv Radiol; 2019 Jan; 30(1):10-18. PubMed ID: 30580809
[TBL] [Abstract][Full Text] [Related]
42. Optimized Performance of FlightPlan during Chemoembolization for Hepatocellular Carcinoma: Importance of the Proportion of Segmented Tumor Area.
Joo SM; Kim YP; Yum TJ; Eun NL; Lee D; Lee KH
Korean J Radiol; 2016; 17(5):771-8. PubMed ID: 27587967
[TBL] [Abstract][Full Text] [Related]
43. C-arm cone-beam CT parenchymal blood volume imaging for transarterial chemoembolization of hepatocellular carcinoma: implications for treatment planning and response.
O'Donohoe RL; Kavanagh RG; Cahalane AM; Houlihan DD; McCann JW; Ryan ER
Eur Radiol Exp; 2019 May; 3(1):21. PubMed ID: 31144237
[TBL] [Abstract][Full Text] [Related]
44. Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.
Wang Z; Chapiro J; Schernthaner R; Duran R; Chen R; Geschwind JF; Lin M
Acad Radiol; 2015 Jul; 22(7):840-5. PubMed ID: 25863795
[TBL] [Abstract][Full Text] [Related]
45. mRECIST criteria and contrast-enhanced US for the assessment of the response of hepatocellular carcinoma to transarterial chemoembolization.
Moschouris H; Malagari K; Papadaki MG; Kornezos I; Stamatiou K; Anagnostopoulos A; Chatzimichael K; Kelekis N
Diagn Interv Radiol; 2014; 20(2):136-42. PubMed ID: 24317334
[TBL] [Abstract][Full Text] [Related]
46. Dose Optimization of Perfusion-derived Response Assessment in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: Comparison of Volume Perfusion CT and Iodine Concentration.
Thaiss WM; Haberland U; Kaufmann S; Hepp T; Schulze M; Blum AC; Ketelsen D; Nikolaou K; Horger M; Sauter AW
Acad Radiol; 2019 Sep; 26(9):1154-1163. PubMed ID: 30482626
[TBL] [Abstract][Full Text] [Related]
47. Sensitivity and Reproducibility of Automated Feeding Artery Detection Software during Transarterial Chemoembolization of Hepatocellular Carcinoma.
Chiaradia M; Izamis ML; Radaelli A; Prevoo W; Maleux G; Schlachter T; Mayer J; Luciani A; Kobeiter H; Tacher V
J Vasc Interv Radiol; 2018 Mar; 29(3):425-431. PubMed ID: 29402612
[TBL] [Abstract][Full Text] [Related]
48. Clinical application of transcatheter arterial chemoembolization combined with synchronous C-arm cone-beam CT guided radiofrequency ablation in treatment of large hepatocellular carcinoma.
Wang ZJ; Wang MQ; Duan F; Song P; Liu FY; Wang Y; Yan JY; Li K; Yuan K
Asian Pac J Cancer Prev; 2013; 14(3):1649-54. PubMed ID: 23679250
[TBL] [Abstract][Full Text] [Related]
49. Intraprocedural cone-beam CT with parenchymal blood volume assessment for transarterial chemoembolization guidance: Impact on the effectiveness of the individual TACE sessions compared to DSA guidance alone.
Peisen F; Maurer M; Grosse U; Nikolaou K; Syha R; Artzner C; Bitzer M; Horger M; Grözinger G
Eur J Radiol; 2021 Jul; 140():109768. PubMed ID: 33991970
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
[TBL] [Abstract][Full Text] [Related]
51. Assessment of treatment success and short-term effectiveness using C-arm CT immediately after hepatic chemoembolization of HCC.
Choi WJ; Jeong WK; Kim Y; Kim J; Song SY; Lee S; Kim YH; Park CK
Hepatogastroenterology; 2014; 61(133):1353-8. PubMed ID: 25436310
[TBL] [Abstract][Full Text] [Related]
52. Parenchymal Blood Volume Assessed by C-Arm-Based Computed Tomography in Immediate Posttreatment Evaluation of Drug-Eluting Bead Transarterial Chemoembolization in Hepatocellular Carcinoma.
Syha R; Grözinger G; Grosse U; Maurer M; Zender L; Horger M; Nikolaou K; Ketelsen D
Invest Radiol; 2016 Feb; 51(2):121-6. PubMed ID: 26488373
[TBL] [Abstract][Full Text] [Related]
53. Transarterial Chemoembolization of HCC with Radiopaque Microspheres: Evaluation with Computed Tomography and the Complementary Role of Contrast-Enhanced Ultrasonography.
Moschouris H; Malagari K; Dimakis A; Kiakidis T; Anagnostopoulou A
Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1075-1083. PubMed ID: 32394087
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of cone-beam computed tomography during transcatheter arterial chemoembolization for hepatocellular carcinoma.
Miyayama S; Yamashiro M; Hattori Y; Orito N; Matsui K; Tsuji K; Yoshida M; Matsui O
Jpn J Radiol; 2011 Jul; 29(6):371-7. PubMed ID: 21786092
[TBL] [Abstract][Full Text] [Related]
55. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
Takizawa K; Numata K; Morimoto M; Kondo M; Nozaki A; Moriya S; Ishii T; Oshima T; Fukuda H; Okada M; Takebayashi S; Maeda S; Tanaka K
Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188
[TBL] [Abstract][Full Text] [Related]
56. Quantitative Automated Segmentation of Lipiodol Deposits on Cone-Beam CT Imaging Acquired during Transarterial Chemoembolization for Liver Tumors: A Deep Learning Approach.
Malpani R; Petty CW; Yang J; Bhatt N; Zeevi T; Chockalingam V; Raju R; Petukhova-Greenstein A; Santana JG; Schlachter TR; Madoff DC; Chapiro J; Duncan J; Lin M
J Vasc Interv Radiol; 2022 Mar; 33(3):324-332.e2. PubMed ID: 34923098
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic accuracy of contrast-enhanced dynamic CT for small hypervascular hepatocellular carcinoma and assessment of dynamic enhancement patterns: Results of two-year follow-up using cone-beam CT hepatic arteriography.
Choi YR; Chung JW; Yu MH; Lee M; Kim JH
PLoS One; 2018; 13(9):e0203940. PubMed ID: 30231076
[TBL] [Abstract][Full Text] [Related]
58. Dual-phase cone-beam computed tomography to see, reach, and treat hepatocellular carcinoma during drug-eluting beads transarterial chemo-embolization.
Tacher V; Lin M; Bhagat N; Abi Jaoudeh N; Radaelli A; Noordhoek N; Carelsen B; Wood BJ; Geschwind JF
J Vis Exp; 2013 Dec; (82):50795. PubMed ID: 24326874
[TBL] [Abstract][Full Text] [Related]
59. Radiation Dose during Transarterial Radioembolization: A Dosimetric Comparison of Cone-Beam CT and Angio-CT Technologies.
Marshall EL; Guajardo S; Sellers E; Gayed M; Lu ZF; Owen J; Funaki B; Ahmed O
J Vasc Interv Radiol; 2021 Mar; 32(3):429-438. PubMed ID: 33358328
[TBL] [Abstract][Full Text] [Related]
60. C-Arm Cone Beam Computed Tomography Guidance for Radiofrequency Ablation in Hepatocellular Carcinoma.
Kato K; Abe H; Ika M; Yonezawa T; Sato Y; Hanawa N; Shimizu S; Endo S; Matsuo R; Tsubota A
Oncology; 2017; 92(3):142-152. PubMed ID: 28052301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
